SUBSCRIBE
SUBSCRIBE
News   Business

NOXXON Pharma AG Announces Appointment of Lawrence E. Posner to Its Board of Directors

July 8, 2008 | 
1 min read
BERLIN--(BUSINESS WIRE)--NOXXON Pharma AG (NOXXON), developer of mirror image oligonucleotide therapeutics termed Spiegelmers®, announced today the appointment of Lawrence E. Posner, MD, to its Board of Directors.
People Europe
MORE ON THIS TOPIC
Creative pattern made with a syringe on pastel pink background. Vaccine for Coronavirus infection. Pandemic concept.
Vaccines
Sales of Merck’s 4-Way Measles Vaccine Take Hit as US Dips Into Stockpile
April 24, 2025
 · 
2 min read
 · 
Annalee Armstrong
Roche's tower in Shanghai, China
Tariffs
Roche in ‘Very, Very Good Position’ To Weather Trump Tariffs but M&A May Suffer
April 24, 2025
 · 
2 min read
 · 
Tristan Manalac
New York City, New York United States - August 29 2021: NASDAQ, National Association of Securities Dealers Automated Quotations corporate logo sign near Times Square.
IPO
Swiss ADC Biotech Takes SPAC Track to NASDAQ
April 23, 2025
 · 
1 min read
 · 
Annalee Armstrong
Creative sketch collage of business people handshake gesture approval project development success colleagues cooperation support.
Deals
Genentech Offers up to $765M in Biobucks to Repertoire for I&I Drug Discovery
April 23, 2025
 · 
1 min read
 · 
Dan Samorodnitsky